DK2526425T3 - Fremgangsmåde til diagnosticering af endometriel receptivitet - Google Patents
Fremgangsmåde til diagnosticering af endometriel receptivitetInfo
- Publication number
- DK2526425T3 DK2526425T3 DK11700679.1T DK11700679T DK2526425T3 DK 2526425 T3 DK2526425 T3 DK 2526425T3 DK 11700679 T DK11700679 T DK 11700679T DK 2526425 T3 DK2526425 T3 DK 2526425T3
- Authority
- DK
- Denmark
- Prior art keywords
- diagnostication
- endometric
- receptivity
- procedure
- endometric receptivity
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/42—Gynaecological or obstetrical instruments or methods
- A61B17/425—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
- A61B17/435—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation for embryo or ova transplantation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/104165—Lipid, cholesterol, or triglyceride standard or control
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Surgery (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Transplantation (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10382011A EP2348318A1 (en) | 2010-01-21 | 2010-01-21 | Diagnostic method for endometrial receptivity |
| PCT/EP2011/050867 WO2011089240A1 (en) | 2010-01-21 | 2011-01-21 | Diagnostic method for endometrial receptivity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2526425T3 true DK2526425T3 (da) | 2014-08-04 |
Family
ID=42200845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11700679.1T DK2526425T3 (da) | 2010-01-21 | 2011-01-21 | Fremgangsmåde til diagnosticering af endometriel receptivitet |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20130144114A1 (enExample) |
| EP (2) | EP2348318A1 (enExample) |
| JP (1) | JP5732664B2 (enExample) |
| CN (1) | CN102792166B (enExample) |
| BR (1) | BR112012018289A2 (enExample) |
| CA (1) | CA2787582A1 (enExample) |
| DK (1) | DK2526425T3 (enExample) |
| ES (1) | ES2485847T3 (enExample) |
| PL (1) | PL2526425T3 (enExample) |
| WO (1) | WO2011089240A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010010201A1 (es) | 2008-07-22 | 2010-01-28 | Equipo Ivi Investigacion Sl | Perfil de expresion genetica como marcador de la receptividad endometrial |
| US9107696B2 (en) * | 2008-08-06 | 2015-08-18 | Emory University | Method of embryo transfer that eliminates transferred air while hormonally inducing implantation and apparatus |
| KR101747983B1 (ko) | 2009-08-22 | 2017-06-15 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 배아, 난모세포, 그리고 줄기 세포의 이미징과 평가 |
| CN103517676A (zh) | 2010-09-27 | 2014-01-15 | 奥克索金股份有限公司 | 用于胚胎、卵母细胞和干细胞的自动化成像和评价的装置、方法和系统 |
| CN103460038A (zh) | 2011-02-23 | 2013-12-18 | 里兰斯坦福初级大学理事会 | 检测人类胚胎中的非整倍性的方法 |
| WO2013135836A1 (en) * | 2012-03-14 | 2013-09-19 | Centre Hospitalier Universitaire Pontchaillou | Itih5 as a diagnostic marker of uterine development and functional defects |
| EP2687851A1 (en) | 2012-07-20 | 2014-01-22 | Matricelab Innove | Method for increasing implantation success in assisted fertilization |
| ES2755878T3 (es) | 2013-02-01 | 2020-04-24 | Ares Trading Sa | Fenotipos anormales de singamia observados con obtención de imágenes a intervalos de tiempo preestablecidos para identificación precoz de embriones con potencial de desarrollo inferior |
| RU2562559C1 (ru) * | 2014-05-27 | 2015-09-10 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт акушерства и гинекологии им. Д.О. Отта" Северо-Западного отделения Российской академии медицинских наук | Способ прогнозирования рецептивности эндометрия в циклах экстракорпорального оплодотворения |
| BR112016029558A2 (pt) | 2014-06-17 | 2017-08-22 | Igenomix S L | terapia de células-tronco em patologias endometriais |
| CN105486799B (zh) * | 2016-01-25 | 2017-12-01 | 中国药科大学 | 用于诊断急性冠脉综合征的代谢标志物 |
| CN105445408B (zh) * | 2016-01-25 | 2018-06-12 | 齐炼文 | 诊断区分冠状动脉粥样硬化和稳定型心绞痛的代谢标志物 |
| EP3545107A2 (en) * | 2016-11-22 | 2019-10-02 | Quantbio Kft | Determination of the receptive status of the endometrium |
| RU2651762C1 (ru) * | 2017-06-14 | 2018-04-23 | Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) | Способ оценки рецептивности эндометрия в период "имплантационного окна" |
| EP3569718A1 (en) * | 2018-05-16 | 2019-11-20 | Integrated Genetic Lab Services SLU | Kit and method for determining the receptivity status of an endometrium |
| EP3914915A1 (en) * | 2019-01-25 | 2021-12-01 | Fertility Lab Sciences, LLC | Uterine endometrial fluid for prediction of success in fertility treatment |
| WO2020160612A1 (en) * | 2019-02-05 | 2020-08-13 | The University Of Sydney | Uterine receptivity |
| EP3779455A1 (en) * | 2019-08-14 | 2021-02-17 | Asociación Centro de Investigación Cooperativa en Biociencias - CIC bioGUNE | Lipid signatures for determining the outcome of embryo implantation during in vitro fertilization |
| CN111505311A (zh) * | 2020-04-30 | 2020-08-07 | 深圳市锦欣医疗科技创新中心有限公司 | 一组胚胎反复种植失败的生物标志物、其筛选方法及应用 |
| CN111505312A (zh) * | 2020-04-30 | 2020-08-07 | 深圳市锦欣医疗科技创新中心有限公司 | 一组子宫内膜受容性的生物标志物、其筛选方法及应用 |
| US20220186312A1 (en) * | 2020-12-11 | 2022-06-16 | Guzip Biomarkers Corporation | Predictive method for assessing the success of embryo implantation |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05501541A (ja) * | 1989-05-05 | 1993-03-25 | ノーザン シドニー エリア ヘルス サーヴィス | 繁殖力増強 |
| GB0201284D0 (en) | 2002-01-21 | 2002-03-06 | Isis Innovation | Screening methods for contraceptive and fertility agents |
| EP1511863A4 (en) * | 2002-05-14 | 2006-12-27 | Univ Leland Stanford Junior | ENDOMETRIAL GENES FOR THE DETECTION OF ENDOMETRIAL DISORDERS |
| ATE338763T1 (de) * | 2002-08-02 | 2006-09-15 | Schering Ag | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie |
| DE10236405A1 (de) * | 2002-08-02 | 2004-02-19 | Schering Ag | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie |
| JP2007504807A (ja) * | 2003-09-08 | 2007-03-08 | ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム | 培養培地にプロスタグランジン又はプロスタグランジン類似物を補足することによってインビトロ胚発生を高めるための方法及び組成 |
| JP2008501035A (ja) * | 2004-05-28 | 2008-01-17 | アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ | 妊孕性関連障害の治療におけるｉｌ−１７の使用 |
| JP2007278750A (ja) * | 2006-04-04 | 2007-10-25 | Ono Pharmaceut Co Ltd | プロスタグランジン類及びその類縁体の定量方法 |
-
2010
- 2010-01-21 EP EP10382011A patent/EP2348318A1/en not_active Withdrawn
-
2011
- 2011-01-21 WO PCT/EP2011/050867 patent/WO2011089240A1/en not_active Ceased
- 2011-01-21 US US13/574,291 patent/US20130144114A1/en not_active Abandoned
- 2011-01-21 ES ES11700679.1T patent/ES2485847T3/es active Active
- 2011-01-21 BR BR112012018289-7A patent/BR112012018289A2/pt not_active IP Right Cessation
- 2011-01-21 CN CN201180010375.0A patent/CN102792166B/zh not_active Expired - Fee Related
- 2011-01-21 PL PL11700679T patent/PL2526425T3/pl unknown
- 2011-01-21 CA CA2787582A patent/CA2787582A1/en not_active Abandoned
- 2011-01-21 JP JP2012549374A patent/JP5732664B2/ja not_active Expired - Fee Related
- 2011-01-21 DK DK11700679.1T patent/DK2526425T3/da active
- 2011-01-21 EP EP11700679.1A patent/EP2526425B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011089240A1 (en) | 2011-07-28 |
| CN102792166B (zh) | 2015-10-21 |
| CN102792166A (zh) | 2012-11-21 |
| EP2348318A1 (en) | 2011-07-27 |
| US20130144114A1 (en) | 2013-06-06 |
| JP5732664B2 (ja) | 2015-06-10 |
| JP2013518244A (ja) | 2013-05-20 |
| CA2787582A1 (en) | 2011-07-28 |
| EP2526425B1 (en) | 2014-04-30 |
| ES2485847T3 (es) | 2014-08-14 |
| BR112012018289A2 (pt) | 2021-04-20 |
| HK1177636A1 (zh) | 2013-08-23 |
| PL2526425T3 (pl) | 2014-11-28 |
| EP2526425A1 (en) | 2012-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2558105T3 (da) | Bardoxolonmethyl til behandling af fedme | |
| DK3329775T3 (da) | Fremgangsmåder til syntese af diarylthiohydantoin- og diarylhydantoinforbindelser | |
| DK2498771T3 (da) | Anvendelse af bethanechol til behandling af xerostomi | |
| DK3192520T3 (da) | Terapeutiske midler til reducering af niveauerne af parathyreoideahormon | |
| DK4122383T3 (da) | Sem-scanner til tidlig opdagelse af sår | |
| CR20120576A (es) | Inhibidores de pirazolil quinazolina cinasa | |
| DK2496562T3 (da) | Fremgangsmåde til fremstilling af calcobutrol | |
| DK3412687T3 (da) | Fremgangsmåder til behandling af dlbcl | |
| EP2580249A4 (en) | MODIFYING XYLAN | |
| DK2595948T3 (da) | Fremgangsmåde til fremstilling af ingenol-3-angelat | |
| DK2635282T3 (da) | Sammensætninger til behandling af myelofibrose | |
| DK3985979T3 (da) | Fremgangsmåde til bestemmelse af referenceenhed | |
| DK2555704T3 (da) | Visning af hæmostatiske parametre | |
| DK3299356T3 (da) | Fremgangsmåde til fremstilling af pleuromutiliner | |
| EP2768515A4 (en) | GLUCOSYLSTEVIA COMPOSITION | |
| DK2506840T3 (da) | Anvendelser af hæmmere af hypoksi-fremkaldende faktorer | |
| DK2462108T3 (da) | Fremgangsmåde til fremstilling af pyrazolcarboxylsyreamider | |
| DK2516359T3 (da) | Fremgangsmåde til fremstilling af ethylbenzen | |
| EP2629616A4 (en) | SUBSTITUTED AMINO-TRIAZOLYL-PDE10-HEMMER | |
| DK2616101T3 (da) | Fremgangsmåde til oprensning af pegyleret erythropoietin | |
| DK2872536T3 (da) | Fremgangsmåde til ekstraktion af biomasse | |
| DK2582776T3 (da) | Fremgangsmåde til opdræt af ascidier | |
| DK2558473T3 (da) | Fremgangsmåde til fremstilling af dithiin-tetracarboximider | |
| DK2681377T3 (da) | Arrangement til fjernelse af istapper | |
| DK2493860T3 (da) | Fremgangsmåde til fremstilling af 4-sulfinylpyrazolderivater |